IQVIA Holdings IncNYSE:IQV
- LAST PRICE211.4800
- TODAY'S CHANGE (%)1.2900 (0.6137%)
- Bid / Lots211.4900/ 8
- Ask / Lots211.7400/ 8
- Open / Previous Close208.9800 / 210.1900
- Day Range
- 52 Week Range
- Volume386,515
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IQV |
|---|---|---|
| 09:32 ET | 11402 | 207.95 |
| 09:33 ET | 900 | 209.3 |
| 09:35 ET | 1000 | 209.43 |
| 09:37 ET | 1129 | 208.69 |
| 09:39 ET | 707 | 209 |
| 09:42 ET | 1741 | 209 |
| 09:44 ET | 500 | 209.06 |
| 09:46 ET | 200 | 209 |
| 09:48 ET | 2473 | 209.555 |
| 09:50 ET | 7522 | 210.8 |
| 09:51 ET | 8194 | 209.79 |
| 09:53 ET | 4602 | 210.245 |
| 09:55 ET | 7740 | 210.405 |
| 09:57 ET | 5132 | 210.735 |
| 10:00 ET | 800 | 210.9825 |
| 10:02 ET | 438 | 211.1964 |
| 10:04 ET | 4404 | 210.99 |
| 10:06 ET | 3911 | 211.27 |
| 10:08 ET | 3908 | 210.39 |
| 10:09 ET | 900 | 210.56 |
| 10:11 ET | 800 | 210.97 |
| 10:13 ET | 1431 | 211.125 |
| 10:15 ET | 2098 | 211.315 |
| 10:18 ET | 11512 | 211.49 |
| 10:20 ET | 1211 | 211.52 |
| 10:22 ET | 1184 | 211.45 |
| 10:24 ET | 3681 | 211.51 |
| 10:26 ET | 5339 | 211.805 |
| 10:27 ET | 2212 | 211.845 |
| 10:29 ET | 2052 | 211.835 |
| 10:31 ET | 2990 | 211.43 |
| 10:33 ET | 1189 | 211.06 |
| 10:36 ET | 4884 | 210.395 |
| 10:38 ET | 700 | 210.71 |
| 10:40 ET | 14851 | 210.63 |
| 10:42 ET | 3066 | 211.16 |
| 10:44 ET | 1256 | 211.12 |
| 10:45 ET | 1800 | 211.25 |
| 10:47 ET | 20224 | 211.305 |
| 10:49 ET | 3112 | 211.195 |
| 10:51 ET | 300 | 210.93 |
| 10:54 ET | 1241 | 209.32 |
| 10:56 ET | 574 | 209.57 |
| 10:58 ET | 2286 | 209.675 |
| 11:00 ET | 5307 | 209.69 |
| 11:02 ET | 670 | 209.61 |
| 11:03 ET | 600 | 209.58 |
| 11:05 ET | 2970 | 209.88 |
| 11:07 ET | 3156 | 210.225 |
| 11:09 ET | 2437 | 210.345 |
| 11:12 ET | 700 | 210.275 |
| 11:14 ET | 8648 | 210.19 |
| 11:18 ET | 884 | 210.005 |
| 11:20 ET | 2900 | 210.08 |
| 11:21 ET | 1974 | 210.285 |
| 11:23 ET | 1160 | 210.145 |
| 11:25 ET | 18429 | 210.095 |
| 11:27 ET | 2208 | 210.05 |
| 11:30 ET | 100 | 210.04 |
| 11:32 ET | 206 | 210.18 |
| 11:34 ET | 1500 | 210.64 |
| 11:36 ET | 912 | 210.9099 |
| 11:38 ET | 9343 | 211.215 |
| 11:39 ET | 707 | 211.24 |
| 11:41 ET | 3077 | 210.99 |
| 11:43 ET | 300 | 211 |
| 11:45 ET | 592 | 210.925 |
| 11:48 ET | 4102 | 210.85 |
| 11:50 ET | 1290 | 211.04 |
| 11:52 ET | 6488 | 211.1 |
| 11:54 ET | 3808 | 211.4 |
| 11:56 ET | 791 | 211.525 |
| 11:57 ET | 5853 | 211.47 |
| 11:59 ET | 1247 | 211.49 |
| 12:01 ET | 1100 | 211.41 |
| 12:03 ET | 200 | 211.3 |
| 12:06 ET | 520 | 211.16 |
| 12:08 ET | 1328 | 211.25 |
| 12:10 ET | 300 | 211.355 |
| 12:12 ET | 449 | 211.4197 |
| 12:14 ET | 1000 | 211.08 |
| 12:15 ET | 800 | 211.32 |
| 12:17 ET | 1300 | 211.56 |
| 12:19 ET | 500 | 211.45 |
| 12:21 ET | 165 | 211.48 |
Today
Yesterday
DJ IQVIA Holdings Is Maintained at Buy by Truist Securities, from 10:47AM ET on Monday Nov 04, 2024 by Dow Jones
10:47AM ET on Monday Nov 04, 2024 by Dow JonesDJ IQVIA Holdings Is Maintained at Overweight by Morgan Stanley, from 8:23AM ET on Monday Nov 04, 2024 by Dow Jones
8:23AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
DJ IQVIA Holdings Is Maintained at Buy by BTIG, from 3:14PM ET on Friday Nov 01, 2024 by Dow Jones
3:14PM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IQVIA Holdings Inc | 38.3B | 27.7x | +46.62% |
Biogen Inc | 25.3B | 15.9x | -18.14% |
ICON PLC | 18.1B | 25.0x | +4.68% |
Regeneron Pharmaceuticals Inc | 91.4B | 20.6x | +10.93% |
Moderna Inc | 20.6B | -3.4x | --- |
Biontech SE | 25.9B | -50.0x | --- |
Company Information
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
Contact Information
- Headquarters
- 2400 ELLIS ROADDURHAM, NC, United States 27703
- Phone
- 919-998-2000
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer
- Ari Bousbib
- Interim Chief Financial Officer, Executive Vice President
- Ronald Bruehlman
- President - Research and Development Solutions
- Walter Staub
- Executive Vice President, General Counsel, Secretary
- Eric Sherbet
- Lead Independent Director
- John Leonard
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.3B |
|---|---|
Revenue (TTM) | $15.3B |
Shares Outstanding | 182.3M |
IQVIA Holdings Inc does not pay a dividend. | |
Beta | 1.52 |
EPS | $7.62 |
Book Value | $33.67 |
P/E Ratio | 27.7x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 15.1x |
Operating Margin | 13.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
